Inflammation, Polyphenols, and Genetics
| Status: | Completed |
|---|---|
| Conditions: | Obesity Weight Loss |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 55 - Any |
| Updated: | 4/21/2016 |
| Start Date: | March 2012 |
| End Date: | May 2012 |
Inflammation, Polyphenols, and Genetics: A Pilot Study in Overweight and Obese Adult Males to Determine Whether Black-Raspberry Consumption Affects Markers of Inflammation in Study Participants Fed a High-Fat, High-Calorie Challenge Meal
Pilot study to determine whether daily consumption of blackraspberry powder (high in
polyphenols) can reduce markers of inflammation and to determine whether genetics influence
baseline levels of inflammatory markers as well as individual's response to polyphenols. A
total of 10 males participated in this cross-over study.
polyphenols) can reduce markers of inflammation and to determine whether genetics influence
baseline levels of inflammatory markers as well as individual's response to polyphenols. A
total of 10 males participated in this cross-over study.
A high-fat, high-calorie challenge meal is administered to induce an inflammatory response
in overweight and obese adult males. Serum levels of CRP, TNF-alpha, and IL-6 are measured
prior to the challenge meal and at various times (1,2,4,8, and 12 hours) after the challenge
meal. The challenge meal is given once without intervention and once after 5 daily doses of
concentrated black-raspberry powder mixed in water.
in overweight and obese adult males. Serum levels of CRP, TNF-alpha, and IL-6 are measured
prior to the challenge meal and at various times (1,2,4,8, and 12 hours) after the challenge
meal. The challenge meal is given once without intervention and once after 5 daily doses of
concentrated black-raspberry powder mixed in water.
Inclusion Criteria:
- adult males over 55 years of age
- overweight or obese
Exclusion Criteria:
- history of adverse reaction to berries or berry products
- history of adverse reaction to high-fat, high-calorie challenge meal
- significant liver or renal insufficiency
- significant cognitive impairment
We found this trial at
1
site
Click here to add this to my saved trials
